EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-Nutritive Sweetened Beverages Impair Therapeutic Benefits of Metformin in Prediabetic Diet-Induced Obese Mice

Arashdeep Singh iD, Katelyn Rourk iD, Angelina Bernier iD, Guillaume de Lartigue

Nutrients · 2023

DOI: 10.3390/nu15112472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Arashdeep Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, High Fructose Corn Syrup, Metformin, Non-Nutritive Sweeteners. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin, a frontline therapy for type 2 diabetes and related metabolic diseases, results in variable outcomes. This study aimed to investigate whether sweetened beverages (caloric or non-caloric) affect the therapeutic benefits of metformin on glucose, food intake, and weight loss in diet-induced obesity. Mice were given a high-fat diet and sweetened water for 8 weeks to induce obesity and glucose intolerance. Then, mice were randomized to receive metformin in either water, high-fructose corn syrup (HFCS), or the non-nutritive sweetener saccharin for 6 weeks. After 6 weeks of metformin treatment, all groups had improved glucose tolerance compared to pretreatment. However, saccharin resulted in worse glucose tolerance and weight gain outcomes than the water or HFCS groups and correlated with lower plasma growth differentiation factor 15 levels. In conclusion, reducing non-nutritive sweetener consumption during metformin therapy is recommended to avoid impairing the therapeutic effects of metformin on body weight and glucose homeostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2High Fructose Corn SyrupMetforminNon-Nutritive SweetenersPrediabetic StateSugar-Sweetened BeveragesAnimalsMiceDiet, High-FatMice, ObeseObesitySaccharinGlucose Intolerance

Stichwörter der Autor:innen

artificial sweetenersdiabeteshigh-fat dietobesitysugar

Substanzen

High Fructose Corn SyrupMetforminNon-Nutritive SweetenersSaccharin

Autor:innen und Institutionen

  • Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA.
  • Monell Chemical Senses Center, Philadelphia, PA 19104, USA.
  • Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19019, USA.
  • Mayo Clinic Alix School of Medicine, College of Medicine and Science, Rochester, MN 55905, USA.
  • Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.

ORCID-Profile: Arashdeep Singh, Katelyn Rourk, Angelina Bernier

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Singh, A., Rourk, K., Bernier, A., & de Lartigue, G. (2023). Non-Nutritive Sweetened Beverages Impair Therapeutic Benefits of Metformin in Prediabetic Diet-Induced Obese Mice. Nutrients. https://doi.org/10.3390/nu15112472

Vancouver

Singh A, Rourk K, Bernier A, de Lartigue G. Non-Nutritive Sweetened Beverages Impair Therapeutic Benefits of Metformin in Prediabetic Diet-Induced Obese Mice. Nutrients. 2023. doi:10.3390/nu15112472

BibTeX
@article{Singh2023,
  author = {Singh, Arashdeep and Rourk, Katelyn and Bernier, Angelina and de Lartigue, Guillaume},
  title = {Non-Nutritive Sweetened Beverages Impair Therapeutic Benefits of Metformin in Prediabetic Diet-Induced Obese Mice},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15112472}
}
Kostenlos starten →